ESTRO 2024 - Abstract Book

S2589

Clinical - Urology

ESTRO 2024

Conclusion:

The study did not find a significant impact of ACEi administration on acute GU toxicity. Given that the bladder is within the clinical target volume, the use of chemoradiation might have overwhelmed any potential radioprotective effects of ACEi in this patient population. This study has inherent limitations, including its retrospective nature and a relatively small sample size. Further larger, prospective studies are needed to investigate this hypothesis further.

Keywords: Bladder cancer, Genitourinary toxicity

2943

Digital Poster

Ultra hypofractionated radiotherapy in high risk prostate cancer: a real world experience

Giulia Corrao 1 , Chiara Lorubbio 1,2 , Ilaria Repetti 1,2 , Maria Giulia Vincini 1 , Mattia Zaffaroni 1 , Federico Mastroleo 3,1 , Cristiana Iuliana Fodor 1 , Pierini Vanessa 1,2 , Giovanni Carlo Mazzola 1 , Pedone Cristiana 1,2 , Dario Zerini 1 , Giulia Marvaso 1 , Barbara Alicja Jereczek-Fossa 1,2